Identification of genetic risk factors associated with ischaemic stroke in young Mexican patients

被引:7
|
作者
Jimenez-Gonzalez, M. C. [1 ]
Santiago-German, D. [2 ]
Castillo-Henkel, E. F. [1 ]
Alvarado-Moreno, J. A. [3 ]
Hernandez-Juarez, J. [3 ]
Leanos-Miranda, A. [4 ]
Majluf-Cruz, A. [3 ]
Isordia-Salas, I. [3 ]
机构
[1] Inst Politecn Nacl, Escuela Super Med, Secc Estudios Posgrad & Invest, Ciudad De Mexico, Mexico
[2] Inst Mexicano Seguro Social, HGR 1 Dr Carlos Mac Gregor Sanchez Navarro, Serv Urgencias, Ciudad De Mexico, Mexico
[3] Inst Mexicano Seguro Social, HGR 1 Dr Carlos Mac Gregor Sdnchez Navarro, Unidad Invest Mod Trombosis Hemostasia & Aterogen, Ciudad De Mexico, Mexico
[4] UMAE HGO 4 Inst Mexicano Seguro Social, Unidad Invest Mod Med Reprod, Ciudad De Mexico, Mexico
来源
NEUROLOGIA | 2021年 / 36卷 / 05期
关键词
TAFI; PAI-1; PG IIb/IIIa; eNOS; 5,10 MTHFR; Ischaemic stroke; ACTIVATABLE FIBRINOLYSIS INHIBITOR; NITRIC-OXIDE; TAFI GENE; POLYMORPHISM; DISEASE; THROMBOSIS; IIB/IIIA;
D O I
10.1016/j.nrl.2018.01.010
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Numerous polymorphisms in candidate genes coding for haemostatic system proteins have been proposed as risk factors for thrombosis. Methods: We performed a case-control study of consecutive ischaemic stroke survivors aged <= 45 years, treated at our neurology department from 2006 to 2014. Polymerase chain reaction-restriction fragment length polymorphism identified the following polymorphisms: Thr325Ile and Ala147Thr in TAFI, 4G/5G in PAI-1, PLA1/A2 in platelet glycoprotein IIb/IIIa, Glu298Asp in eNOS, and C677T in 5,10-MTHFR. A multivariate logistic regression analysis was performed to evaluate the independent risk of stroke. Results: 204 cases and 204 age- and sex-matched controls were included in the study. Clinical and genetic variables associated with ischaemic stroke were hypertension (P=.03), tobacco use (P=.02), and the polymorphisms Glu298Asp (genotype: P=.001, allele frequency: P=.001) and C677T (genotype: P=.01); the Ala147Thr, Thr325IIe, 4G/5G, and PLA1/A2 mutations were not associated with ischaemic stroke. The 298Asp (P=.03) and T (P=.01) alleles, hypertension (P=.03), tobacco use (P=.01) and family history of stroke (P=.04) were identified as independent risk factors. Conclusions: The polymorphisms Glu298Asp and C677T, affecting the eNOS and 5,10-MTHFR enzymes, respectively, and smoking, hypertension, and family history of stroke were associated with ischaemic stroke in young Mexican patients; this was not the case for the Thr325Ile, Ala147Thr, 4G/5G, and PLA1/A2 polymorphisms of the genes coding for fibrinolytic proteins and platelet receptors. (C) 2018 Sociedad Espanola de Neurologia. Published by Elsevier Espana, S.L.U.
引用
收藏
页码:337 / 345
页数:9
相关论文
共 50 条
  • [1] ISCHAEMIC STROKE AETIOLOGY, RISK FACTORS AND CLINICAL OUTCOMES IN YOUNG PATIENTS
    Cetiner, Mustafa
    Cam, Mustafa
    Kabay, Sibel Canbaz
    Aydin, Hasan Emre
    Ayas, Selahattin
    Temel, Ozge
    Zorlu, Yasar
    ACTA MEDICA MEDITERRANEA, 2018, 34 (04): : 1019 - 1025
  • [2] Risk factors associated with ischaemic stroke in Guadeloupe
    Bangou-Bredent, J
    Lannuzel, A
    Foucan, L
    Dartigues, JF
    Caparros-Lefebvre, D
    WEST INDIAN MEDICAL JOURNAL, 2000, 49 (04): : 302 - 306
  • [3] Vascular risk factors in patients with ischaemic stroke
    Gonzalez-Hernandez, A.
    Fabre-Pi, O.
    Lopez-Fernandez, J. C.
    REVISTA DE NEUROLOGIA, 2008, 47 (03) : 167 - 167
  • [4] Risk factors of ischaemic stroke in patients with atrial fibrillation
    Tracz, Justyna
    Gorczyca-Glowacka, Iwona
    Walek, Pawel
    Rosolowska, Anita
    Wozakowska-Kaplon, Beata
    MEDICAL STUDIES-STUDIA MEDYCZNE, 2023, 39 (01) : 8 - 13
  • [5] Risk factors for ischaemic stroke
    Allen, Claire L.
    Bayraktutan, Ulvi
    INTERNATIONAL JOURNAL OF STROKE, 2008, 3 (02) : 105 - 116
  • [6] Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke
    Charles C. Esenwa
    Mitchell S. Elkind
    Nature Reviews Neurology, 2016, 12 : 594 - 604
  • [7] Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke
    Esenwa, Charles C.
    Elkind, Mitchell S.
    NATURE REVIEWS NEUROLOGY, 2016, 12 (10) : 594 - 604
  • [8] Prevalence and risk factors of ischaemic stroke in the young: a regional Australian perspective
    Siriratnam, Pakeeran
    Godfrey, Amelia
    O'Connor, Ellie
    Pearce, Dora
    Hu, Chih-Chiang
    Low, Ashlea
    Hair, Casey
    Oqueli, Ernesto
    Sharma, Anand
    Kraemer, Thomas
    Sahathevan, Ramesh
    INTERNAL MEDICINE JOURNAL, 2020, 50 (06) : 698 - 704
  • [9] Risk factors, aetiology and outcome of ischaemic stroke in young adults: the Swiss Young Stroke Study (SYSS)
    Simonetti, Barbara Goeggel
    Mono, Marie-Luise
    Huynh-Do, Uyen
    Michel, Patrik
    Odier, Celine
    Sztajzel, Roman
    Lyrer, Philippe
    Engelter, Stefan T.
    Bonati, Leo
    Gensicke, Henrik
    Traenka, Christopher
    Tettenborn, Barbara
    Weder, Bruno
    Fischer, Urs
    Galimanis, Aekaterini
    Jung, Simon
    Luedi, Rudolf
    De Marchis, Gian Marco
    Weck, Anja
    Cereda, Carlo W.
    Baumgartner, Ralf
    Bassetti, Claudio L.
    Mattle, Heinrich P.
    Nedeltchev, Krassen
    Arnold, Marcel
    JOURNAL OF NEUROLOGY, 2015, 262 (09) : 2025 - 2032
  • [10] Ischaemic stroke in the young adult: Clinical features, risk factors and outcome
    Nayak, SD
    Nair, M
    Radhakrishnan, K
    Sarma, PS
    NATIONAL MEDICAL JOURNAL OF INDIA, 1997, 10 (03): : 107 - 112